Banner

AMO buys Pfizer's surgical ophthalmology unit

Article

Advanced Medical Optics Inc. (AMO) brought something special to San Diego for this week's American Society of Cataract and Refractive Surgery meeting-the surgical ophthalmology business formerly owned by Pfizer.

Related Videos
Related Content

World Retina Day: Iveric Bio focusing on GA awareness with More to See campaign

September 24th 2023

EyePod: Week in Review - September 17, 2023

September 23rd 2023

World Retina Day: New data from Kiora Pharmaceuticals shines a light on inherited retinal diseases

September 24th 2023

EyePod: Week in Review - September 10, 2023

September 16th 2023

Adding tools and techniques to your skillset: Real World Ophthalmology

September 23rd 2023

Foundation Fighting Blindness awards $900,000 to MitoChem Therapeutics to study target and mechanism of action in retinal degeneration disease

September 22nd 2023

World Retina Day: Iveric Bio focusing on GA awareness with More to See campaign

September 24th 2023

EyePod: Week in Review - September 17, 2023

September 23rd 2023

World Retina Day: New data from Kiora Pharmaceuticals shines a light on inherited retinal diseases

September 24th 2023

EyePod: Week in Review - September 10, 2023

September 16th 2023

Adding tools and techniques to your skillset: Real World Ophthalmology

September 23rd 2023

Foundation Fighting Blindness awards $900,000 to MitoChem Therapeutics to study target and mechanism of action in retinal degeneration disease

September 22nd 2023

World Retina Day: Iveric Bio focusing on GA awareness with More to See campaign

September 24th 2023

EyePod: Week in Review - September 17, 2023

September 23rd 2023

World Retina Day: New data from Kiora Pharmaceuticals shines a light on inherited retinal diseases

September 24th 2023

EyePod: Week in Review - September 10, 2023

September 16th 2023

Adding tools and techniques to your skillset: Real World Ophthalmology

September 23rd 2023

Foundation Fighting Blindness awards $900,000 to MitoChem Therapeutics to study target and mechanism of action in retinal degeneration disease

September 22nd 2023
© 2023 MJH Life Sciences

All rights reserved.